High incidence of Helicobacter pylori infection in patients with systemic sclerosis: Association with sicca syndrome

International Journal of Immunopathology and Pharmacology

Volumn 14, Issue 2, 2001, Pages 81-85

  Farina, G ^a   Rosato, E ^a   Francia, C ^a   Proietti, M ^a   Donato, G ^a   Ammendolea, C ^a   Pisarri, S ^a   Salsano, F ^a  

^a Dipartimento di Medicina Clinica   (Italy)

Author keywords

Helicobacter infection; Sicca syndrome; Systemic sclerosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL SYMPTOM; HELICOBACTER PYLORI; HUMAN; INCIDENCE; MALE; PRIORITY JOURNAL; SCHIRMER TEST; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS; XEROSTOMIA;

EID: 0034892012     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Gastro-intestinal manifestations of scleroderma
2. Organ manifestation in 100 patients with progressive systemic sclerosis: A comparison between the CREST syndrome and diffuse scleroderma
3. Phatogenesis of systemic sclerosis: A vascular hypothesis
4. The pathogenesis of esophageal dysfunction in scleroderma and Raynaud ës disease
5. Gastrointestinal features of scleroderma
6. Gastrointestinal manifestations of systemic sclerosis
7. Ischaemia of the small intestine in patients with systemic sclerosis: Raynaud's phenomenon or cronic vasculopathy?
8. Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis
9. Detection of early asymptomatic esophageal dysfunction in systemic sclerosis using a new scintigraphic grading method
10. Barrett's epithelium in scleroderma
11. Gastrointestinal motility disorders in scleroderma
12. Helicobacter pylori associated gastritis and primary B-cell limphoma
13. An international association between Helicobacter pylori infection and gastric cancer
14. Helicobacter pylori infection and extradigestive diseases
15. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States
16. Helicobacter pylori in patients with systemic sclerosis: Detection with the 13 C-urea breath test and eradication
17. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjogren's syndrome
18. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: Association with esophageal involvement
19. Sjogren's syndrome and Helicobacter pylori infection
20. Lymphocyte infiltrations of the gastric mucosa in Sjogren's syndrome
21. Atrophic gastritis in Sjogren's syndrome
22. Gastric involvement in primary Sjogren's syndrome
23. Gastric classified in accordance with the Sydney System in patients with primary Sjogren's syndrome
24. Diagnosis
25. Pathology and autoimmunity
26. Helicobacter pylori and gastroesophageal reflux disease
27. Incidence of H. Pylori infection in patients with rheumatic diseases
28. Helicobacter Pylori infection rate increases after treatment of achalasia
29. Autoimmune diseases and H. Pylori infection
30. Lack of correlation between gastric H. Pylori infection and primary or secondary Raynaud's phenomenon in patients with systemic sclerosis
31. Role of intragastric autoantibodies in chronic H. Pylori infection
32. Presence of autoantibodies against H. Pilori and its heat-shock protei 60 in the serum of patients with Sjogren's syndrome
33. Relationship between H. Pylori, gastric parietal cell antibodies and heat shock proteins
34. Anti-CagA antibodies cross-react with human platelet antigens
35. Adhesion of different strains of H. Pylori to Salivary Glycoproteins